原发性肾病综合征与血清超敏C反应蛋白相关分析被引量：4

Correlation between ultrasensitive C-reactive protein and primary nephrotic syndrome

导出

摘要目的:探讨C反应蛋白(CRP)与原发性肾病综合征(PNS)的关系.方法:采用免疫散射比浊法测定超敏C反应蛋白(hsCRP),观察76例PNS患者和健康对照组的血清hsCRP以及其它指标的水平.结果:PNS患者血清hsCRP水平较对照组明显升高.Pearson相关分析显示hsCRP与质量指数(BMI)、收缩压(SBP)和舒张压(DBP)成正相关(P<0.05),逐步线性回归分析显示BMI是影响hsCRP的主要因素.结论:PNS患者体内存在以血清hsCRP升高为代表的微炎症反应,并且与患者的BMI,SBP和DBP明显相关,但是与蛋白尿、低白蛋白血症以及高脂血症等PNS的并发症无相关性. AIM： To investigate the correlation between C-reactive protein （CRP） and primary nephrotic syndrome （PNS）. METHODS： Seventy-six patients with PNS and 40 healthy subjects were included in the study. The serum high sensitivity C-reactive protein （hsCRP） and other related indexes were measured and analyzed. RESULTS：The level of hsCRP in patients with PNS was significantly higher than that in control group. Pearson correlation analysis indicated that the hsCRP level was positively correlated with body mass index （BMI） , systolic blood pressure （SBP） and diastolic blood pressure （DBP）（ P 〈 0.05 ）. Stepwise linear regression showed a linear correlation between BMI and hsCRP. CONCLUSION： Microinflammation featured by increased hsCRP level exists in patients with PNS, and the hsCRP level is associated with BMI and blood pressure but not with complications of PNS, such as proteinuria, hypoproteinemia and hyperlipoidcmia.

作者杨世峰尹爱萍谭峰杨亚丽

机构地区西安交通大学医学院第一附属医院肾脏内科

出处《第四军医大学学报》 CAS 北大核心 2009年第16期1520-1522,共3页 Journal of the Fourth Military Medical University

关键词肾病综合征 C反应蛋白质人体质量指数血压 nephrotie syndrome C-reactive protein body mass index blood pressure

分类号 R692.3 [医药卫生—泌尿科学]

引文网络
相关文献

参考文献11

1Pogan A, Sancewicz-Pach K, Miezynski W. TNF-alpha and soluble interleukin-2 receptor and glomerular sclerosis in primary nephrotic syndrome in children[J]. Wiad Lek, 2005,58( 1 ) : 39-44.
2Kilis'-Pstrusinska K, Medynska A, Zwolinska D, et al. Interleukin-18 in urine and serum of children with idiopathic nephrotic syndrome [J]. Kidney Blood Press Res, 2008,31 (2) : 122 -126.
3王海燕郑法雷等.原发性肾小球疾病分型与治疗及诊断标准专题座谈会纪要[J].中华内科杂志,1993,2:131-134.
4权晓娟,王妮,姜素珍,张水利,张莹.血清C-反应蛋白与2型糖尿病肾病相关分析[J].第四军医大学学报,2007,28(24):2267-2268. 被引量：24
5Tsioufis C, Dimitriadis K, Chatzis D, et al. Relation of microalbuminuria to adiponectin and augmented C-reactive protein levels in men with essential hypertension [ J ]. Am J Cardiol, 2005,96 ( 7 ) :946 -951.
6吕萍,李自成,常青.高血压病患者C反应蛋白变化的临床意义[J].第二军医大学学报,2005,26(9):1034-1036. 被引量：24
7Sesso HD, Wang L, Buring JE, et al. Comparison of interleukin-6 and C-reactive protein for the risk of developing hypertension in women [J]. Hypertension, 2007,49(2) : 304 -310.
8De Haro J, Acin F, Lopez-Quintana A, et al. Direct association between C-reactive protein serum levels and endothelial dysfunction in patients with claudication [ J ]. Eur J Vasc Endovasc Surg, 2008, 35(4) : 480-486.
9孟宪华,冉岩,吴瑞杰,蔡迪娅,郑治纲.体重指数对C反应蛋白浓度的影响[J].现代检验医学杂志,2005,20(5):74-75. 被引量：3
10Won CW,Lee SW,Choi HR,et al. Body mass index and C-reactive protein in the healthy Korean aged men[ J]. J Korean Med Sci, 2006,21(5) : 811 -815.

二级参考文献27

1廖岚,雷闽湘,陈慧玲,郭丽娟.高敏c-反应蛋白与2型糖尿病视网膜病变[J].中国医学工程,2004,12(6):25-28. 被引量：14
2张淑芳,汪海东,曹春玲,王丽.老年2型糖尿病患者尿微量白蛋白与C反应蛋白及胰岛素抵抗关系的临床观察[J].中国医学工程,2005,13(1):20-21. 被引量：26
3Maseri A. Inflammation,atherosclerosis and ischemic events-exploring the hidden side of the moon[J]. N Engl J Med,1997;336:1014-1016.
4Muhlestein JB,Horne BD,Carlquist JF,et al. Cytomegalovirus seropositivity and C-reactive protein have independent and combined predicative value for mortality in patients with angiographically demonstrated coronary artery disease[J]. Circulation, 2000;102:1917-1923.
5Farmer JA,Gotto AM Jr. Dyslipidemia and other risk factors for coronary artery disease. in :Braun wald E,editor. Heart Disease: A textbook of cardiovascular medicine [M]. 5thed. Philadelphia. Saunders, 1997:1126-1160.
6Hotamisligil GS,Arner P,Caro JF,et al. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance [J]. J Clin Invest, 1995; 95: 2409-2415.
7Kern PA,Saghizadeh M,Ong JM,et al. The expression of tumor necrosis factor in human adipose tissue: regulation by obesity, weight loss, and relationship to lipoprotein lipase [J]. J Clin Invest, 1995 ; 95:2111-2119.
8Warren RS,Starnes HF Jr,Gabrilove JL,et al. The acute metabolic effects of tumor necrosis factor administration in humans [J]. Arch Surg, 1987; 122:1396-1400.
9Hotamisligil GS,Shargill NS,Spiegelman BM. Adipose expression of tumor necrosis factor-alpha:direct role in obesity linked insulin resistance[J]. Science, 1993 ; 259: 87-91.
10Hirokawa J, Sakaue S. Furuya Y, et al. Tumor necrosis factor-alpha regulates the gene expression of macrophage migration inhibitory factor throgh tyrosine kinase-dependent pathway in 3T3-L1 adipocytes [J]. J Biochem (Tokyo), 1998; 123: 733-739.